CA1035350A - Steroides substitues en position 7 de la serie des oestranes - Google Patents
Steroides substitues en position 7 de la serie des oestranesInfo
- Publication number
- CA1035350A CA1035350A CA197,175A CA197175A CA1035350A CA 1035350 A CA1035350 A CA 1035350A CA 197175 A CA197175 A CA 197175A CA 1035350 A CA1035350 A CA 1035350A
- Authority
- CA
- Canada
- Prior art keywords
- steroids
- series substituted
- oestrane series
- oestrane
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7305171A NL7305171A (fr) | 1973-04-13 | 1973-04-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1035350A true CA1035350A (fr) | 1978-07-25 |
Family
ID=19818634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA197,175A Expired CA1035350A (fr) | 1973-04-13 | 1974-04-09 | Steroides substitues en position 7 de la serie des oestranes |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3944576A (fr) |
| JP (1) | JPS5024262A (fr) |
| AT (1) | AT349658B (fr) |
| BE (1) | BE813702A (fr) |
| CA (1) | CA1035350A (fr) |
| DE (1) | DE2417846A1 (fr) |
| DK (1) | DK134757B (fr) |
| ES (1) | ES425224A1 (fr) |
| FI (1) | FI53707C (fr) |
| FR (1) | FR2225163B1 (fr) |
| GB (1) | GB1469650A (fr) |
| HU (1) | HU170245B (fr) |
| IE (1) | IE39192B1 (fr) |
| NL (1) | NL7305171A (fr) |
| PH (1) | PH12082A (fr) |
| SE (1) | SE405364B (fr) |
| ZA (1) | ZA741999B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4265823A (en) * | 1979-01-04 | 1981-05-05 | Robert E. Kosinski | Aurothiosteroids |
| SU1170969A3 (ru) * | 1982-07-06 | 1985-07-30 | Др.Карл Томэ,Гмбх (Фирма) | Способ получени производных фенилуксусной кислоты или их солей |
| US20070129282A1 (en) * | 1998-11-24 | 2007-06-07 | Ahlem Clarence N | Pharmaceutical treatments and compositions |
| ES2246234T3 (es) * | 1999-05-04 | 2006-02-16 | Strakan International Limited | Glicosidos de androgenos y actividad androgenica de los mismos. |
| DE60045751D1 (de) | 1999-09-30 | 2011-04-28 | Harbor Biosciences Inc | Therapeutische Behandlung androgenrezeptorbedingter Leiden |
| GB0025221D0 (en) * | 2000-10-14 | 2000-11-29 | Astrazeneca Ab | New process |
| US7910755B2 (en) * | 2004-09-29 | 2011-03-22 | Harbor Biosciences, Inc. | Stem cell expansion and uses |
-
1973
- 1973-04-13 NL NL7305171A patent/NL7305171A/xx not_active Application Discontinuation
-
1974
- 1974-03-27 US US05/455,488 patent/US3944576A/en not_active Expired - Lifetime
- 1974-03-27 GB GB1362174A patent/GB1469650A/en not_active Expired
- 1974-03-28 ZA ZA00741999A patent/ZA741999B/xx unknown
- 1974-03-28 IE IE675/74A patent/IE39192B1/xx unknown
- 1974-04-04 PH PH15707A patent/PH12082A/en unknown
- 1974-04-09 CA CA197,175A patent/CA1035350A/fr not_active Expired
- 1974-04-09 FI FI1077/74A patent/FI53707C/fi active
- 1974-04-10 DK DK201674AA patent/DK134757B/da unknown
- 1974-04-10 ES ES425224A patent/ES425224A1/es not_active Expired
- 1974-04-10 JP JP49040663A patent/JPS5024262A/ja active Pending
- 1974-04-11 DE DE19742417846 patent/DE2417846A1/de active Pending
- 1974-04-11 SE SE7405000A patent/SE405364B/xx unknown
- 1974-04-12 HU HUAO381A patent/HU170245B/hu unknown
- 1974-04-12 BE BE143192A patent/BE813702A/fr unknown
- 1974-04-12 FR FR7412945A patent/FR2225163B1/fr not_active Expired
- 1974-04-16 AT AT313574A patent/AT349658B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HU170245B (fr) | 1977-05-28 |
| FI53707C (fi) | 1978-07-10 |
| AU6753174A (en) | 1975-10-09 |
| FI53707B (fr) | 1978-03-31 |
| NL7305171A (fr) | 1974-10-15 |
| DK134757B (da) | 1977-01-10 |
| IE39192B1 (en) | 1978-08-16 |
| ZA741999B (en) | 1975-03-26 |
| FR2225163A1 (fr) | 1974-11-08 |
| ES425224A1 (es) | 1976-05-16 |
| FR2225163B1 (fr) | 1978-07-21 |
| ATA313574A (de) | 1978-09-15 |
| SE405364B (sv) | 1978-12-04 |
| DE2417846A1 (de) | 1974-10-24 |
| GB1469650A (en) | 1977-04-06 |
| JPS5024262A (fr) | 1975-03-15 |
| IE39192L (en) | 1974-10-13 |
| BE813702A (fr) | 1974-10-14 |
| US3944576A (en) | 1976-03-16 |
| DK134757C (fr) | 1977-05-31 |
| AT349658B (de) | 1979-04-25 |
| PH12082A (en) | 1978-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU473714B2 (en) | Anti-inflammatory steroids of the androstane series | |
| PH11410A (en) | Novel steroids | |
| CA1015742A (en) | Steroids | |
| CA1035350A (fr) | Steroides substitues en position 7 de la serie des oestranes | |
| CA1006156A (en) | Steroids of the pregnane series | |
| AU488962B2 (en) | NOVEL lip-ALKYL STEROIDS OFTHE ESTRANE SERIES | |
| CA1025435A (fr) | D-homo steroides | |
| CA993094A (en) | Versatile fuse panel | |
| AU489907B2 (en) | Novel steroids ofthe oestrane series substituted in 7-position | |
| AU463920B2 (en) | 17-alkadienyl substituted steroids | |
| AU477992B2 (en) | Steroids | |
| AU480545B2 (en) | Novel steroids | |
| AU480546B2 (en) | Novel steroids | |
| AU463919B2 (en) | 17-alkadienyl steroid | |
| AU480725B2 (en) | Novel d-homo steroids | |
| CA892572A (en) | Steroids of the pregnane series | |
| AU6420174A (en) | Steroids | |
| AU7263274A (en) | Novel steroids | |
| AU471575B2 (en) | Novel steroids | |
| AU451348B2 (en) | Novel steroids of the pregnane series | |
| CA891486A (en) | A-furan steroids | |
| CA895284A (en) | Steroids | |
| AU485903B2 (en) | 2-2-dimethyl steroids | |
| AU7014874A (en) | Haptene steroids | |
| AU484644B2 (en) | Corticosteroids |